These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

658 related articles for article (PubMed ID: 20843562)

  • 1. The global need for effective antibiotics: challenges and recent advances.
    Högberg LD; Heddini A; Cars O
    Trends Pharmacol Sci; 2010 Nov; 31(11):509-15. PubMed ID: 20843562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic resistance: how it arises, the current position and strategies for the future.
    Perry C; Hall C
    Nurs Times; 2009 Sep 15-21; 105(36):20-3. PubMed ID: 19835196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The global need for effective antibiotics-a summary of plenary presentations.
    Alvan G; Edlund C; Heddini A
    Drug Resist Updat; 2011 Apr; 14(2):70-6. PubMed ID: 21440487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The global need for effective antibiotics-moving towards concerted action.
    Cars O; Hedin A; Heddini A
    Drug Resist Updat; 2011 Apr; 14(2):68-9. PubMed ID: 21444235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Better control of antibiotic resistance.
    Guillemot D; Courvalin P;
    Clin Infect Dis; 2001 Aug; 33(4):542-7. PubMed ID: 11462192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A framework for global surveillance of antibiotic resistance.
    Grundmann H; Klugman KP; Walsh T; Ramon-Pardo P; Sigauque B; Khan W; Laxminarayan R; Heddini A; Stelling J
    Drug Resist Updat; 2011 Apr; 14(2):79-87. PubMed ID: 21482177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the pharmaceutical industry in meeting the public health threat of antibacterial resistance.
    Bergström R
    Drug Resist Updat; 2011 Apr; 14(2):77-8. PubMed ID: 21493123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late stage antibacterial drugs in the clinical pipeline.
    Projan SJ; Bradford PA
    Curr Opin Microbiol; 2007 Oct; 10(5):441-6. PubMed ID: 17950658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. All EU hands to the EU pumps: the Science Academies of Europe (EASAC) recommend strong support of research to tackle antibacterial resistance.
    Gyssens IC
    Clin Microbiol Infect; 2008 Oct; 14(10):889-91. PubMed ID: 18828849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotics and antibiotic resistance genes in natural environments.
    Martínez JL
    Science; 2008 Jul; 321(5887):365-7. PubMed ID: 18635792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The need for new antibiotics.
    Livermore DM
    Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():1-9. PubMed ID: 15522034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents.
    Allahverdiyev AM; Kon KV; Abamor ES; Bagirova M; Rafailovich M
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1035-52. PubMed ID: 22029522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Old and new targets of antibacterial therapy.
    Dbaibo GS
    J Med Liban; 2000; 48(4):177-81. PubMed ID: 11214186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic use: present and future.
    Zinner SH
    New Microbiol; 2007 Jul; 30(3):321-5. PubMed ID: 17802919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Future antibiotics scenarios: is the tide starting to turn?
    Theuretzbacher U
    Int J Antimicrob Agents; 2009 Jul; 34(1):15-20. PubMed ID: 19342202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New macrolide, lincosaminide and streptogramin B antibiotics.
    Kirst HA
    Expert Opin Ther Pat; 2010 Oct; 20(10):1343-57. PubMed ID: 20645886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The etiological structure of the causative agents of inflammatory nonspecific urological diseases and the dynamics of their resistance to the widely used antibiotics].
    Derevianko NI; Kotliarova GA; Kondrat'eva EM; Nefedova LA; Kudriashova EE
    Urol Nefrol (Mosk); 1997; (3):13-8. PubMed ID: 9245048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antibiotic R&D pipeline: an update.
    Jabes D
    Curr Opin Microbiol; 2011 Oct; 14(5):564-9. PubMed ID: 21873107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of antibiotic-resistant pathogens in the community.
    Yagupsky P
    Pediatr Infect Dis J; 2006 Oct; 25(10):974-6. PubMed ID: 17006309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.